The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma

被引:173
作者
Steen, Chloe [1 ,2 ]
Luca, Bogdan [2 ,3 ]
Esfahani, Mohammad [1 ]
Azizi, Armon [2 ]
Sworder, Brian [1 ]
Nabet, Barzin [4 ]
Kurtz, David [1 ]
Liu, Chih [1 ]
Khameneh, Farnaz [2 ]
Advani, Ranjana [1 ]
Natkunam, Yasodha [5 ]
Myklebust, June [6 ,7 ]
Diehn, Maximilian [4 ]
Gentles, Andrew [2 ,3 ,9 ]
Newman, Aaron [2 ,8 ,9 ]
Alizadeh, Ash [1 ,8 ,9 ]
机构
[1] Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA
[3] Stanford Univ, Stanford Ctr Biomed Informat Res, Dept Med, Stanford, CA 94305 USA
[4] Stanford Univ, Dept Radiat Oncol, Med Ctr, Stanford, CA 94305 USA
[5] Stanford Univ, Dept Pathol, Med Ctr, Stanford, CA 94305 USA
[6] Oslo Univ Hosp, Inst Canc Res, Dept Canc Immunol, Oslo, Norway
[7] Univ Oslo, KG Jebsen Ctr B Cell Malignancies, Inst Clin Med, Oslo, Norway
[8] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA
[9] Stanford Univ, Stanford Canc Inst, Stanford, CA 94305 USA
关键词
GENE-EXPRESSION; BRENTUXIMAB VEDOTIN; PD-1; BLOCKADE; NIVOLUMAB; RITUXIMAB; SUBSETS; DISEASE; MICROENVIRONMENT; CLASSIFICATION; PEMBROLIZUMAB;
D O I
10.1016/j.ccell.2021.08.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Biological heterogeneity in diffuse large B cell lymphoma (DLBCL) is partly driven by cell-of-origin subtypes and associated genomic lesions, but also by diverse cell types and cell states in the tumor microenvironment (TME). However, dissecting these cell states and their clinical relevance at scale remains challenging. Here, we implemented EcoTyper, a machine-learning framework integrating transcriptome deconvolution and single-cell RNA sequencing, to characterize clinically relevant DLBCL cell states and ecosystems. Using this approach, we identified five cell states of malignant B cells that vary in prognostic associations and differentiation status. We also identified striking variation in cell states for 12 other lineages comprising the TME and forming cell state interactions in stereotyped ecosystems. While cell-of-origin subtypes have distinct TME composition, DLBCL ecosystems capture clinical heterogeneity within existing subtypes and extend beyond cell-of-origin and genotypic classes. These results resolve the DLBCL microenvironment at systems-level resolution and identify opportunities for therapeutic targeting (https://ecotyper.stanford.eduilymphoma).
引用
收藏
页码:1422 / +
页数:26
相关论文
共 94 条
[1]   CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma [J].
Advani, Ranjana ;
Flinn, Ian ;
Popplewell, Leslie ;
Forero, Andres ;
Bartlett, Nancy L. ;
Ghosh, Nilanjan ;
Kline, Justin ;
Roschewski, Mark ;
LaCasce, Ann ;
Collins, Graham P. ;
Thu Tran ;
Lynn, Judith ;
Chen, James Y. ;
Volkmer, Jens-Peter ;
Agoram, Balaji ;
Huang, Jie ;
Majeti, Ravindra ;
Weissman, Irving L. ;
Takimoto, Chris H. ;
Chao, Mark P. ;
Smith, Sonali M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (18) :1711-1721
[2]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[3]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[4]   Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients [J].
Alvaro, Tomas ;
Lejeune, Marylene ;
Salvado, Maria-Teresa ;
Lopez, Carlos ;
Jaen, Joaquin ;
Bosch, Ramon ;
Pons, Lluis E. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) :5350-5357
[5]   Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints [J].
Andor, Noemi ;
Simonds, Erin F. ;
Czerwinski, Debra K. ;
Chen, Jiamin ;
Grimes, Susan M. ;
Wood-Bouwens, Christina ;
Zheng, Grace X. Y. ;
Kubit, Matthew A. ;
Greer, Stephanie ;
Weiss, William A. ;
Levy, Ronald ;
Ji, Hanlee P. .
BLOOD, 2019, 133 (10) :1119-1129
[6]  
[Anonymous], 2000, STAT BIOL HEALTH
[7]  
[Anonymous], 1958, Magyar Tud Akad Mat Kutato Int Kozl
[8]   PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma [J].
Ansell, Stephen M. ;
Lesokhin, Alexander M. ;
Borrello, Ivan ;
Halwani, Ahmad ;
Scott, Emma C. ;
Gutierrez, Martin ;
Schuster, Stephen J. ;
Millenson, Michael M. ;
Cattry, Deepika ;
Freeman, Gordon J. ;
Rodig, Scott J. ;
Chapuy, Bjoern ;
Ligon, Azra H. ;
Zhu, Lili ;
Grosso, Joseph F. ;
Kim, Su Young ;
Timmerman, John M. ;
Shipp, Margaret A. ;
Armand, Philippe .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :311-319
[9]   Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma [J].
Aoki, Tomohiro ;
Chong, Lauren C. ;
Takata, Katsuyoshi ;
Milne, Katy ;
Hav, Monirath ;
Colombo, Anthony ;
Chavez, Elizabeth A. ;
Nissen, Michael ;
Wang, Xuehai ;
Miyata-Takata, Tomoko ;
Lam, Vivian ;
Vigano, Elena ;
Woolcock, Bruce W. ;
Telenius, Adele ;
Li, Michael Y. ;
Healy, Shannon ;
Ghesquiere, Chanel ;
Kos, Daniel ;
Goodyear, Talia ;
Veldman, Johanna ;
Zhang, Allen W. ;
Kim, Jubin ;
Saberi, Saeed ;
Ding, Jiarui ;
Farinha, Pedro ;
Weng, Andrew P. ;
Savage, Kerry J. ;
Scott, David W. ;
Krystal, Gerald ;
Nelson, Brad H. ;
Mottok, Anja ;
Merchant, Akil ;
Shah, Sohrab P. ;
Steidl, Christian .
CANCER DISCOVERY, 2020, 10 (03) :406-421
[10]   Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure [J].
Armand, Philippe ;
Shipp, Margaret A. ;
Ribrag, Vincent ;
Michot, Jean-Marie ;
Zinzani, Pier Luigi ;
Kuruvilla, John ;
Snyder, Ellen S. ;
Ricart, Alejandro D. ;
Balakumaran, Arun ;
Rose, Shelonitda ;
Moskowitz, Craig H. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (31) :3733-+